| Literature DB >> 27512489 |
B Myers1, R Neal2, O Myers3, M Ruparelia3.
Abstract
Direct oral anticoagulants (DOACs or NOACs -non-vitamin K oral anticoagulants), as the name suggests, are oral anticoagulants with a direct inhibitory action either against factor X or factor II (thrombin). Pregnant women were excluded from participating in all the large trials of the DOACs and they are considered contra-indicated in pregnancy and breast feeding. We present a case of inadvertent exposure to rivaroxaban in a woman who presented at 25 weeks' gestation. The management of her pregnancy and delivery is described, and the previous published case reports are reviewed with a discussion about the use of DOACs in woman of childbearing age.Entities:
Keywords: Anticoagulants; Rivaroxaban; direct oral anticoagulants; heavy menstrual bleeding; pregnancy
Year: 2015 PMID: 27512489 PMCID: PMC4950440 DOI: 10.1177/1753495X15621814
Source DB: PubMed Journal: Obstet Med ISSN: 1753-495X